|
PROCEDURE FOR HANDLING CYTOTOXIC
DRUGS
PURPOSE:
To protect the nursing employee, environment, patient and others from potential
hazards of cytotoxic drugs.
EQUIPMENT:
- Personal Protective Equipment (PPE) -
Gloves
tested for use with hazardous drugs, face shield, disposable
low-permeability gown
- Labeled medication
and
infusion tubing from pharmacy/sealed leak-proof container
- Infusion pump
(unless
administering a vesicant agent through a peripheral site)
-
Cytotoxic waste container (yellow or blue top
container)
-
Chemotherapy Spill Kit
(stored on
unit - available from Environmental Health and Safety or Inpatient
Pharmacy)
NURSING ACTION:
PROCEDURE STEPS:
WHEN OBTAINING CYTOTOXIC MEDICATION
FROM PHARMACY
-
Pharmacy will prime tubing under a biological safety cabinet before
adding cytoxic drug to IV bag. If oral chemotherapy is ordered, liquid dose is
preferred. Avoid crushing chemotherapy tablets or opening capsules.
-
When ready
for floor pickup, all cytotoxic medications will be sealed in
a leak-proof container. Medication will be labeled appropriately. Container
will be labeled as hazardous on the outside.
-
Personnel
obtaining cytotoxic drug from pharmacy will be trained in
recognition of a chemotherapy spill. Personnel will be aware of location of the
nearest spill kit (pharmacy or nursing care area).
-
Personnel
will deliver the cytotoxic drug directly to the RN responsible
for administration or ensure it is immediately secured in the medication room.
PROPER WEAR OF PERSONAL PROTECTIVE
EQUIPMENT
-
Put on gown.
-
Put on face shield.
-
Put on gloves ensuring the glove cuffs are over the gown cuffs.
PROPER REMOVAL OF PERSONAL PROTECTIVE
EQUIPMENT
-
Immediately remove any material that comes in contact with a cytotoxic
agent or when no longer needed.
-
Remove and discard gloves by removing the first and grasping it in the
hand of the other, then pulling the other off so that it contains the first
glove and is wrong side out.
-
Remove and discard gown and face shield.
-
Dispose of all personal protective equipment in cytotoxic waste
container.
WHEN PERFORMING
DOSAGE DOUBLE-CHECKS
-
See-through container: Dosage double-check is performed prior to opening
bag.
-
Non-see-through container: RN administering cytotoxic drug (first RN)
must wear full personal protective equipment prior to opening the leak-proof
container.
-
First RN opens and removes chemotherapy from leak-proof container taking
care to only expose what is necessary to do the dosage check. Second RN holds
the orders and reads them to first RN while first RN looks at the drug label.
-
First RN replaces
and reseals chemotherapy in leak-proof container when dosage check complete.
DURING ADMINISTRATION
-
Place a yellow
or blue top cytotoxic waste container near the area administration
will occur.
-
Wear personal protective equipment.
-
Work below eye level.
-
Ensure that a spill kit is available.
-
Place a disposable plastic-backed pad on the work area to absorb any
droplets that may spill.
-
Place a gauze pad under the injection site to catch any droplets during
administration.
-
Use only luer-lock connectors (no needles or tape)
-
After administration, remove the bag or bottle with tubing attached. Do
not remove the spike from IV containers or reuse the tubing.
-
Use detergent and water to wash surfaces that come into contact with
hazardous drugs.
-
Discard all contaminated material and PPE in the yellow
or blue top cytotoxic waste
container.
-
Discard all needles and sharps in the sharps container.
AFTER ADMINISTRATION
-
Most cytotoxic agents are excreted in the patient’s body fluids for 48
hours to one week (7 days) after administration. During this time, all caregivers
should wear full personal protective equipment if exposure to body fluids is a
possibility. Avoid splashing body fluids to decrease release of droplets into
the atmosphere.
-
Patients receiving cytotoxic agents will be identified on the
unit by a blue armband with a corresponding Blue High Risk form on front of
the chart and a "SAFE HANDLING PRECAUTIONS" sign on the door.
-
Patient Education will be available on Adobe Acrobat:
"Chemotherapy Exposure Precautions"
-
Place disposable urinals, bedpans, urinary drainage bags and emesis
basins in the cytotoxic waste container at patient’s discharge or when
replacing.
-
Dispose of vomitus and excreta in toilet. Avoid splashing or spraying
which create large amounts of aerosol.
-
Seal cytotoxic waste containers when full for pickup from Environmental
Health and Safety.
DISCHARGE TEACHING
-
If
patient will be going home before the cytotxic drugs are cleared from
their system, provide them with the teaching sheet in Adobe Acrobat “Safe
Management of Body Waste After Chemotherapy.”
REFERENCES:
Oncology Nursing Society Chemotherapy and
Biotherapy Guidelines and Recommendations for Practice 2nd edition
2005.
Oncology Nursing Society Safe Handling of Hazardous Drugs 2003.
Nursing Manual Home Page
Hazardous Drugs and Times for Protective Handling of
Patient Excreta
|
HAZARDOUS DRUG |
DURATION OF DETECTABLE DRUG RESIDUE IN URINE |
DURATION OF DETECTABLE DRUG RESIDUE IN STOOL |
|
ASPARAGINASE |
NOT DETECTABLE |
- |
|
BLEOMYCIN SULFATE |
72 HOURS |
- |
|
BUSULFAN |
24 HOURS |
- |
|
CAPECITABINE |
24 HOURS |
- |
|
CARBOPLATIN |
48 HOURS |
- |
|
CARMUSTINE |
4 DAYS |
- |
|
CHLORAMBUCIL |
48 HOURS |
- |
|
CISPLATIN |
7 DAYS |
- |
|
CYCLOPHOSPHAMIDE |
72 HOURS |
5 DAYS AFTER ORAL DOSE |
|
CYTARABINE HYDROCHLORIDE |
24 HOURS |
- |
|
DACARBAZINE |
6 HOURS |
- |
|
DACTINOMYCIN |
5 DAYS |
- |
|
DAUNORUBICIN HYDROCHLORIDE |
48 HOURS |
7 DAYS |
|
DOCETAXEL |
7 DAYS |
7 DAYS |
|
DOXORUBICIN |
6 DAYS |
7 DAYS |
|
EPIRUBICIN HYDROCHLORIDE |
7 DAYS |
5 DAYS |
|
ETOPOSIDE |
4 DAYS |
7 DAYS |
|
FLUDARABINE |
48 HOURS |
- |
|
GEMCITABINE |
7 DAYS |
- |
|
HYDROXYUREA |
12 HOURS |
- |
|
IFOSFAMIDE |
48 HOURS |
- |
|
IMATINIB MESYLATE |
7 DAYS |
- |
|
IRINOTECAN |
48 HOURS |
- |
|
LOMUSTINE |
24 HOURS |
- |
|
MECHLORETHAMINE HYDROCHLORIDE |
48 HOURS |
- |
|
MELPHALAN |
48 HOURS |
7 DAYS |
|
MERCAPTOPURINE |
72 HOURS |
- |
|
METHOTREXATE |
72 HOURS |
7 DAYS |
|
MITOMYCIN |
24 HOURS |
- |
|
MITOXANTRONE HYDROCHLORIDE |
6 DAYS |
7 DAYS |
|
PACLITAXEL |
24 HOURS |
5 DAYS |
|
PEGASPARGASE |
NOT DETECTABLE |
- |
|
TENIPOSIDE |
5 DAYS |
48 HOURS |
|
THIOGUANINE |
24 HOURS |
- |
|
THIOTEPA |
24 HOURS |
- |
|
VINBLASTINE SULFATE |
4 DAYS |
7 DAYS |
|
VINCRISTINE SULFATE |
4 DAYS |
7 DAYS |
From ONS Safe Handling of Hazardous Drugs 2003.
|